Press Releases 2016

Biophytis presents preliminary clinical data of SARA-PK, and new preclinical data of Sarconeos for treating sarcopenia. Read the Press Release

BIOPHYTIS Announces Successful Completion of SARA-PK Clinical Study for Sarconeos in Sarcopenia Confirming Safety Profile. Read the Press Release

Conférence Biotech Agora – December 13, 2016 18h45 – Hôtel ATALA, 10 Rue de Chateaubriand, 75008

BIOPHYTIS received regulatory authorizations to conduct SARA-OBS study in sarcopenia patients. Read the Press Release

Biophytis Presenting Four Posters on Sarconeos at 9th International Conference on Cachexia, Sarcopenia, and Muscle Wasting. Read the Press Release

BIOPHYTIS to attend to Jefferies conference (London) and European Midcap event (Geneva). Read the Press Release

BIOPHYTIS chooses Patheon to produce the clinical batches of Macuneos, its AMD drug candidate that will enter Phase 2B. Read the Press Release

BIOPHYTIS to implement company’s SARA-data e-Health platform for clinical development of Sarconeos in sarcopenia patients. Read the Press Release

Biophytis to attend the European Large & Midcap Event in Paris – 5-6 October, 2016

Business Update and Consolidated Half-Year Financials as of June 30, 2016. Read the Press Release